REcovery from DEXmedetomidine-Induced Unresponsiveness (REDEX): A Study Protocol for a Single Center, Parallel Arm, Non-Randomized, Controlled Pilot Trial in Healthy Volunteers.
Nature and Science of Sleep 2025 David R Schreier, Matteo Fecchio, Christian S. Guay et al.
Dexmedetomidine (DEX) is a well-tolerated sedative drug that induces a sleep-like state. DEX sedation offers a model to study transitions between different states of consciousness (indicated by, eg, behavior, the electroencephalogram (EEG), or transcranial magnetic stimulation (TMS) evoked EEG responses). However, the effects of repeated DEX exposure on recovery are poorly understood and will...
DOI: 10.2147/NSS.S523111 (opens in new tab)
Full text (opens in new tab)
Consciousness
Electroencephalography
Sleep
Target-controlled infusion
+4